Cardiac Rhythm Management

Healthcare Professionals Cardiac Rhythm Management

MicroPort® CRM is a pioneering company in the physiological management of heart disease using high-tech implantable devices and diagnostic solutions. With dedicated R&D teams and state-of-the-art manufacturing facilities, MicroPort® CRM designs, develops, and markets solutions for the management of heart rhythm disorders, such as implantable pacemakers and defibrillators, as well as heart failure with cardiac resynchronization therapy (CRT), worldwide.

The company is headquartered in Clamart (outside Paris, France), and our world-class technologies are manufactured in France, Italy, the Dominican Republic and China for the Chinese market.

Pacemakers

Our ground breaking research has allowed us to develop the world’s smallest dual chamber pacemaker¹ and the world's first AutoMRI technology to automatically adjust pacemaker settings for MRI scans², just a few examples of our commitment to product innovation.

Click here to know more
ENO DR Micro Port 2018

ICD devices

Our ground breaking research has allowed us to develop the world’s longest lasting implantable defibrillator1 which embeds PARAD+TM a clinically proven arrhythmia discrimination algorithm providing the lowest rate of inappropriate shocks ever reported in the medical literature2, further highlighting our dedication to product innovation.

Click here to know more
Platinium VR

CRT devices

Our ground breaking research has allowed us to develop the world’s longest lasting cardiac resynchronization therapy defibrillators1 and SonRTM, the world’s first and only AV/VV optimization algorithm based on cardiac contractility leading to a 35% risk reduction of HF hospitalization2, just a few examples of our commitment to product innovation.

Click here to know more
PLATINIUM 4 LV CRT D 1744 Micro Port front

Leads

A cardiac lead is the wire connecting pacemakers and ICDs to the heart. It’s a small player with a big role. Discover more about how each lead compliments our cardiac devices.

Click here to know more
XFINE straightand J

Patient management

MicroPort® CRM provides you with SMARTVIEW – a complete solution for patient management. From the moment of implantation and throughout the lifetime of our cardiac devices, we offer intuitive software interfaces from our programmers to our remote monitoring systems featuring comprehensive reports as detailed as traditional in-clinic follow-ups.

Click here to know more
TABLE DOCKING PERS D

Arrhythmia assessment

With more than 30 years of experience in ECG recording tools, MicroPort® CRM produces state-of-the-art technologies that are the gold standard in data acquisition and ECG analysis. Our full range of powerful solutions for arrhythmia diagnostics provides everything essential to your clinical needs.

Click here to know more
GAMME

Availability of select products and their functions vary by country. Please check with your representative for further information.

Blue-Star

Product performance reports

At MicroPort® CRM, we are committed to constantly delivering innovative medical devices and services that meet customer expectations and are safe, effective and compliant with quality standards and regulations.

Click here to know more
Blue star

Grand and Donation

We support educational, charitable, and research endeavors that serve a genuine educational or public health function, benefit society, or that demonstrate good corporate citizenship.

Click here to know more

ICD devices

  1. Competition comparison made as of March 2020, refer to manufacturers manuals and Boston Scientific longevity calculator available online.
    Applicable conditions: A, V=2.5V; 0.4ms; 500ohms; 100% (15% A pacing for Medtronic Cobalt/Crome); VVI for VR models / DDD for DR models; 60 bpm (40bpm for Biotronik Acticor 7 VR-T, Rivacor 3/5/7 VR-T); Sensor ON (OFF for Abbott Gallant, Biotronik Acticor 7, Rivacor 3/5/7, Medtronic Cobalt/Crome); Remote ON; RF telemetry 45min-2h at implant and 15-60min p.a.; 2 battery charges p.a. for capacitor maintenance (1 every 9 months + 4 at implant for Gallant).
  2. Ruiz-Granell R, Dovellini EV, Dompnier A, Khalighi K, García-Campo E, Olivier A, Barcelo A, Ritter P. Algorithm-based reduction of inappropriate defibrillator shock: Results of the Inappropriate Shock Reduction wIth PARAD+ Rhythm DiScrimination-Implantable Cardioverter Defibrillator Study. Heart Rhythm. 2019 Sep;16(9):1429-1435.

CRT devices

  1. Competition comparison made as of March 2020, refer to manufacturers manuals and Boston Scientific longevity calculator available online.
    Applicable conditions: A, RV, LV=2.5V; 0.4ms; 500ohms; 100% (15% A pacing for Medtronic Cobalt/Crome); BiV; 60 bpm; Sensor ON (OFF for Abbott Gallant, Biotronik Acticor 7, Rivacor 3/5/7, Medtronic Cobalt/Crome); CRT optimization system OFF; Remote ON; RF telemetry 1-2h at implant and 15-60 min p.a.; 2 battery charges p.a. for capacitor maintenance (1 every 9 months + 4 at implant for Gallant).
  2. Brugada J, Delnoy PP, Brachmann J, Reynolds D, Padeletti L, Noelker G, Kantipudi C, Rubin Lopez JM, Dichtl W, Borri-Brunetto A, Verhees L, Ritter P, Singh JP; RESPOND CRT Investigators. Contractility sensor-guided optimization of cardiac resynchronization therapy: results from the RESPOND-CRT trial. Eur Heart J. 2017 Mar 7;38(10):730-738.


MICROPORT® CRM Manuals

http://www.microportmanuals.com/